Export

Essential medicine status
ATC codes: C03CA01
EMLc
Indication
Anuria or oliguria ICD11 code: MF51
INN
Furosemide
Medicine type
Chemical agent
List type
Core
Formulations
Parenteral > General injections > IV: 10 mg per mL in 2 mL ampoule
Oral > Liquid: 20 mg per 5 mL (EMLc)
Oral > Solid: 40 mg ; 10 mg (EMLc) ; 20 mg (EMLc)
EML status history
First added in 1977 (TRS 615)
Changed in 1979 (TRS 641)
Changed in 2007 (TRS 950)
Sex
All
Age
Also recommended for children
Therapeutic equivalence
Medicines within the same pharmacological class can be used
Therapeutic equivalence limitations for EMLc
The square box does not apply to the listing of furosemide on the EMLc.
Patent information
Patents have expired in most jurisdictions
Wikipedia
DrugBank
Summary of evidence and Expert Committee recommendations
The EMLc Subcommittee considered that diuretics were essential for use in children in the treatment of ascites, acute or chronic renal failure or acute glomerulonephritis. Nephrotic syndrome oedema responds poorly to diuresis, and loop diuretics may be hazardous because patients are often volume-depleted despite oedema. The Subcommittee endorsed the inclusion of furosemide on the core list of the EMLc, including lower strength tablets (10 mg and 20 mg) and an oral liquid (20 mg/5 mL) formulation.